ASX:VHT

Volpara Health Technologies Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume434,964 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive VHT News and Ratings via Email

Sign-up to receive the latest news and ratings for Volpara Health Technologies and its competitors with MarketBeat's FREE daily newsletter.


About Volpara Health Technologies

Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback for every mammography exam; Volpara Lung, a patient management software that streamlines lung screening workflow, compliance, and reimbursement; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function that calculates volumetric breast density, fibroglandular tissue volume, and breast volume to assign a Volpara Density Grade; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited operates in North America, Europe, the Middle East, Africa, and the APAC countries. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Volpara Health Technologies (ASX:VHT) Frequently Asked Questions

What stocks does MarketBeat like better than Volpara Health Technologies?

Wall Street analysts have given Volpara Health Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Volpara Health Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Volpara Health Technologies' next earnings date?

Volpara Health Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 23rd 2021.
View our earnings forecast for Volpara Health Technologies
.

Who are Volpara Health Technologies' key executives?

Volpara Health Technologies' management team includes the following people:
  • Dr. Ralph Highnam B.Sc., M.Sc., Ph.D., MD, CEO & Director
  • Mr. Craig Hadfield, CFO & Company Sec.
  • Dr. Monica Saini B.Sc., M.D., M.S., Non-Exec. Director & Chief Medical Officer
  • Prof. Nico Karssemeijer, Co-Founder & Member of Scientific Board
  • Mr. Simon Francis, Chief Operating Officer
  • Mr. Gareth Beaumont, Chief Information Officer & Chief Information Security Officer
  • Ms. Kathryn Greene, Chief People Officer
  • Mr. Julian Marshall, Chief Knowledge Officer
  • Mr. Mark P. Morris, Exec. VP
  • Matt Prickett, Sr. VP of Product

Who are some of Volpara Health Technologies' key competitors?

What other stocks do shareholders of Volpara Health Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Volpara Health Technologies investors own include Sabre Resources (SBR), Webjet (WEB), Western Digital (WDC), South32 (S32), Netflix (NFLX), Nearmap (NEA), Charlotte's Web (CWBHF), Aristocrat Leisure (ALL) and AusCann Group (AC8).

What is Volpara Health Technologies' stock symbol?

Volpara Health Technologies trades on the ASX under the ticker symbol "VHT."

How much money does Volpara Health Technologies make?

Volpara Health Technologies has a market capitalization of $0.00 and generates $19.75 million in revenue each year.

How many employees does Volpara Health Technologies have?

Volpara Health Technologies employs 147,000 workers across the globe.

What is Volpara Health Technologies' official website?

The official website for Volpara Health Technologies is volparasolutions.com.

Where are Volpara Health Technologies' headquarters?

Volpara Health Technologies is headquartered at Po Box 2600,V26, Valley Forge, Pennsylvania 19482-2600.

How can I contact Volpara Health Technologies?

Volpara Health Technologies' mailing address is Po Box 2600,V26, Valley Forge, Pennsylvania 19482-2600. The company can be reached via phone at 64 4 499 6029.


This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.